Position
Chief Operating Officer
Company
Mezzion Pharma
Description
Mezzion Pharmaceuticals has appointed Ridwan Shabsigh, MD, FACS to the newly created role of President and Chief Operating Officer. His extensive experience will support the advancement of the company's clinical trial and prepare for potential commercialization.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
- Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs. (February 9, 2026)
- Jubilant Pharmova Appoints Daniel J. O’Connor as Chief Executive Officer (December 2, 2025)
- Vistagen Appoints Nick Tressler as Chief Financial Officer (December 1, 2025)
- Aquestive Therapeutics Appoints Dr. Matthew Greenhawt as Chief Medical Officer (February 18, 2026)
- NuCana Appoints Theresa Bruce as Chief Operating Officer (January 6, 2026)
Who to call at Mezzion Pharma, and when
A new leader at Mezzion Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Mezzion Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mezzion Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mezzion Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mezzion Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Mezzion Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.